Steven Cohen's ZNTL Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 100,290 shares of Zentalis Pharmaceuticals, Inc. (ZNTL) worth $135,392, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in ZNTL, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Zentalis Pharmaceuticals (ZNTL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zentalis Pharmaceuticals (ZNTL) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +100,290 | New Buy | 100,290 | $1.35 |
Steven Cohen's Zentalis Pharmaceuticals Investment FAQs
Steven Cohen first purchased Zentalis Pharmaceuticals, Inc. (ZNTL) in Q4 2025, acquiring 100,290 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Zentalis Pharmaceuticals, Inc. (ZNTL) for 1 quarters since Q4 2025.
Steven Cohen's largest addition to Zentalis Pharmaceuticals, Inc. (ZNTL) was in Q4 2025, adding 100,290 shares worth $135,392.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 100,290 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), valued at approximately $135,392.
As of the Q4 2025 filing, Zentalis Pharmaceuticals, Inc. (ZNTL) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Zentalis Pharmaceuticals, Inc. (ZNTL) was 100,290 shares, as reported at the end of Q4 2025.